Phase I trial: Fortrea Clinical Pharmacology Services 1006539

Category Primary study
Registry of TrialsISRCTN registry
Year 2022
This article has no abstract
Epistemonikos ID: 17e844cc974af539c9ed3b6bc723430281293ee1
First added on: Jan 17, 2025